[
  {
    "ts": null,
    "headline": "Idexx Laboratories price target raised to $460 from $420 at Stifel",
    "summary": "Stifel raised the firm’s price target on Idexx Laboratories (IDXX) to $460 from $420 and keeps a Hold rating on the shares. The firm says that the company’s Q1 results were not surprising, but the stock’s reaction was a bit stronger than expected. Stifel will continue to monitor the uptake of Cancer Dx and inVue, but for now the firm believes the near-term contribution is already reflected in estimates. Published first on TheFly – the ultimate source for real-time, market-moving breaking financi",
    "url": "https://finnhub.io/api/news?id=b84c0494b55a89bbb9f73ad08d0a6808527564b7a8e160b0906d5947a5c80982",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746208827,
      "headline": "Idexx Laboratories price target raised to $460 from $420 at Stifel",
      "id": 134204741,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Stifel raised the firm’s price target on Idexx Laboratories (IDXX) to $460 from $420 and keeps a Hold rating on the shares. The firm says that the company’s Q1 results were not surprising, but the stock’s reaction was a bit stronger than expected. Stifel will continue to monitor the uptake of Cancer Dx and inVue, but for now the firm believes the near-term contribution is already reflected in estimates. Published first on TheFly – the ultimate source for real-time, market-moving breaking financi",
      "url": "https://finnhub.io/api/news?id=b84c0494b55a89bbb9f73ad08d0a6808527564b7a8e160b0906d5947a5c80982"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories [NasdaqGS:IDXX] Raises 2025 Guidance and Reports Q1 Growth in Revenue and EPS",
    "summary": "IDEXX Laboratories (NasdaqGS:IDXX) experienced a 13% price increase over the last month, spurred by robust first-quarter earnings results and an optimistic upward revision in corporate guidance. The company reported an increase in sales and net income compared to the previous year, projecting confidence for the remainder of 2025. These positive events coincided with a broader market uptick, including a strong U.S. jobs report and potential trade talk optimism, both bolstering the S&P 500's...",
    "url": "https://finnhub.io/api/news?id=cfbb01adb13f1ebed5549f0edebf005540bdfe6640597eb52322c14dbcb559b1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746207124,
      "headline": "IDEXX Laboratories [NasdaqGS:IDXX] Raises 2025 Guidance and Reports Q1 Growth in Revenue and EPS",
      "id": 134204743,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDEXX Laboratories (NasdaqGS:IDXX) experienced a 13% price increase over the last month, spurred by robust first-quarter earnings results and an optimistic upward revision in corporate guidance. The company reported an increase in sales and net income compared to the previous year, projecting confidence for the remainder of 2025. These positive events coincided with a broader market uptick, including a strong U.S. jobs report and potential trade talk optimism, both bolstering the S&P 500's...",
      "url": "https://finnhub.io/api/news?id=cfbb01adb13f1ebed5549f0edebf005540bdfe6640597eb52322c14dbcb559b1"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid ...",
    "summary": "IDEXX Laboratories Inc (IDXX) reports robust revenue growth driven by diagnostics and consumables, despite facing headwinds in clinical visits and foreign exchange impacts.",
    "url": "https://finnhub.io/api/news?id=ee2951037010409fdb8389597c22bb17176c442301a6368f9223239283f5249c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746169522,
      "headline": "IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid ...",
      "id": 134185333,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDEXX Laboratories Inc (IDXX) reports robust revenue growth driven by diagnostics and consumables, despite facing headwinds in clinical visits and foreign exchange impacts.",
      "url": "https://finnhub.io/api/news?id=ee2951037010409fdb8389597c22bb17176c442301a6368f9223239283f5249c"
    }
  }
]